Literature DB >> 12544699

Gross chylous ascites in cirrhosis with massive portal vein thrombosis: diagnostic value of lymphoscintigraphy. A case report and review of the literature.

Athanasios J Archimandritis1, Dimitrios I Zonios, Dimitra Karadima, Panagiotis G Vlachoyiannopoulos, Despina Kiriaki, Grigorios S Hatzis.   

Abstract

Chylous ascites is an uncommon condition, which could be due to various causes. We report a case of gross chylous ascites in a patient with cirrhosis and portal vein thrombosis. It is confirmed that gross chylous ascites in a patient with cirrhosis and portal vein thrombosis heralds an ominous prognosis for the patient. Results also demonstrate that common therapeutic interventions confer minimal benefit to the patient, whose survival may be limited to a few months. The use of lymphoscintigraphy as a convenient method for diagnostic exploration of the chylous ascites is emphasized, as it does not lead to complications or adverse effects, and can be readily repeated as needed. Copyright 2003 Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  2003        PMID: 12544699     DOI: 10.1097/00042737-200301000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Hodgkin's disease presenting with chylous ascites and cavernous transformation of the portal vein.

Authors:  Can Gonen; Mesut Akarsu; Dilek Solmaz; Tugbahan Yilmaz; Mustafa Secil; Funda Obuz; Aydanur Kargi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

2.  Atraumatic chylous ascites: an unusual presentation of bladder cancer.

Authors:  Ashish Srinivasan; Ross Apostolov; Amanda Leong; Douglas Johnson
Journal:  BMJ Case Rep       Date:  2017-05-04

3.  Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience.

Authors:  Lia Assumpcao; John L Cameron; Christopher L Wolfgang; Barish Edil; Michael A Choti; Joseph M Herman; Jean-Francois Geschwind; Kelvin Hong; Christos Georgiades; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-08-07       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.